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Abstract
Visit-to-visit variability (VVV) of blood pressure (BP) has been associated with cardiovascular 
disease (CVD) and mortality in some but not all studies. We conducted a systematic review and 
meta-analysis to examine the association between VVV of BP and CVD and all-cause mortality. 
Medical databases were searched through June 4, 2014 for studies meeting the following 
eligibility criteria: adult participants; BP measurements at ≥3 visits; follow-up for CVD, coronary 
heart disease (CHD), stroke, or mortality outcomes; events confirmed via database, death 
certificate, and/or event ascertainment committee; and adjustment for confounders. Data were 
extracted by two reviewers and pooled using a random-effects model. Overall, 8,870 abstracts 
were identified of which 37 studies, representing 41 separate cohorts, met inclusion criteria. 
Across studies, VVV of systolic BP (SBP) and diastolic BP showed significant associations with 
outcomes in 181 of 312 (58.0%) and 61 of 188 (32.4%) analyses, respectively. Few studies 
provided sufficient data for pooling risk estimates. For each 5 mmHg higher SD of SBP, the 
pooled hazard ratios for stroke across seven cohorts was 1.17 (95% CI:1.07–1.28), for CHD across 
four cohorts was 1.27 (95% CI:1.07–1.51), for CVD across five cohorts was 1.12 (95% CI:0.98–
1.28), for CVD mortality across five cohorts was 1.22 (95% CI:1.09–1.35), and for all-cause 
mortality across four cohorts was 1.20 (95% CI:1.05–1.36). In summary, modest associations 
between VVV of BP and CVD and all-cause mortality are present in published studies. However, 
these findings are limited by the small amount of data available for meta-analysis.
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In many individuals, blood pressure (BP) varies between clinic visits conducted days, 
weeks, or months apart. Although long thought to be artifact, recent data suggest that visit-
to-visit variability (VVV) of BP is associated with an increased risk for incident coronary 
heart disease (CHD), stroke, and mortality, independent of mean BP.1–3 Most noteworthy 
was a series of publications in Lancet and Lancet Neurology in 2010 by Rothwell and 
colleagues who showed that VVV of BP was a strong risk factor for stroke, independent of 
mean BP.3–5 These publications stimulated a great deal of interest in VVV of BP as a novel 
risk factor for cardiovascular disease (CVD). More recent findings, however, have yielded 
mixed results regarding the association between VVV of BP and risk for future 
cardiovascular events.6,7 Given the uncertainty of the association between VVV of BP and 
CVD risk, we conducted a systematic review and meta-analysis. Our primary objective was 
to document the association between VVV of BP and CVD, including stroke and CHD, and 
all-cause mortality. Our secondary objective was to document the methodology (e.g., 
number of visits, time interval between visits, etc.) used to estimate VVV of BP in published 
studies.
METHODS
Search Strategy and Selection Criteria
Studies were included if they met the following criteria: (1) adult participants aged 18 years 
and over, (2) measurement of BP at three or more visits on different days, (3) follow-up for 
outcomes of incident CVD, CHD, stroke, or mortality, (4) events confirmed via database, 
death certificate, and/or event ascertainment committee, and (5) adjustment for confounders 
undertaken in the design or analysis stages of the study. We excluded studies that only 
assessed BP variability via ambulatory monitoring, did not use a comparison or referent 
group, or that were reported exclusively in letters to the editor, commentaries, meeting 
abstracts, editorials, or review articles. There was no restriction on language.
The following databases were searched through June 4, 2014: MEDLINE, Database of 
Abstracts of Reviews of Effects (DARE), Health Technology Assessment Database (HTA), 
Cumulative Index to Nursing and Allied Health Literature (CINAHL), Scopus, ProQuest 
Dissertations & Theses (PQDT), and ClinicalTrials.gov. The MEDLINE search strategy is 
described in the online-only Data Supplement. Terms for the other databases were adapted 
accordingly. To supplement the database searches, a PubMed related articles search and a 
cited reference search through ISI Web of Science were conducted using the included 
articles identified from the first set of search results. A manual search was also performed 
using the reference lists from the included articles and the reference lists from review 
articles produced by the electronic database searches.
Two investigators (KMD and RMT) independently reviewed all identified articles for 
eligibility using the above criteria. The title and abstract of identified articles were reviewed 
and those deemed ineligible were excluded. The full-text for the remainder of articles were 
retrieved and reviewed. Discrepancies on whether to include a study were resolved by 
discussion including a third investigator (PM).
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Data were abstracted from all articles by two separate investigators (KMD and RMT), 
independently, using a standardized instrument. Study characteristics (cohort name, sample 
size, population characteristics, country of origin, outcomes, and follow-up period), VVV 
measurement methodology (number of visits used to derive VVV, number of BP readings 
taken at each visit, time interval between visits, BP measurement device, BP indexes 
assessed, VVV metrics quantified, and whether VVV was analyzed as a continuous and/or 
categorical variable), and results (e.g., hazard ratios) from fully adjusted models were 
abstracted for the overall study population and for all subgroups reported. The quality of 
data abstraction was controlled by comparing the forms of the data abstractors. 
Discrepancies in data abstraction were resolved by discussion and by a third investigator 
(PM), when needed. When potentially relevant data were not reported, two attempts were 
made to contact the corresponding author via email. Any data that were not reported in the 
full-text and were not provided by the corresponding author are described as “not reported” 
or “NR”. For this manuscript we describe all included articles as “studies”. As several 
studies reported results from multiple populations, the term “cohort” is used to describe each 
unique population. Finally, for many cohorts, the results from multiple analyses of VVV of 
SBP or VVV of DBP with an outcome were reported. Therefore, each result is referred to as 
an “analysis”.
Statistical Analyses
Meta-analyses were conducted for VVV of SBP and VVV of DBP modeled as continuous 
variables. Analyses were restricted to cohorts in which VVV was quantified as the standard 
deviation (SD) of BP, the most commonly used VVV metric. Pooled hazard ratios (HR) and 
95% confidence intervals (CI) were calculated per 5 mmHg higher SD of BP using a 
random-effects model. Tests for heterogeneity were not conducted because of the small 
amount of data available for pooling each outcome (range: 2 to 7 cohorts). Publication bias 
was assessed by funnel plots and with a regression asymmetry test8 for measures of VVV of 
BP with >10 analyses (pooling all outcomes).9 Data analyses were conducted using Stata 
V11 (Stata Inc., College Station, TX).
RESULTS
The original search identified 6,100 abstracts (Figure 1). Following review of the title and 
abstract, 6,002 abstracts were excluded. Of the 98 full-text articles retrieved, 42 were review 
articles, leaving 56 original articles. An additional 4 potentially relevant articles were 
identified from a manual search of the reference lists from the 42 review articles. Of the 60 
original articles reviewed, 34 were excluded leaving 26 original articles. An additional 11 
original articles were identified from 2,770 abstracts identified in a supplemental search of 
other sources (reference lists, related articles search, citations). In total, of the 8,870 
abstracts retrieved and reviewed from the original and supplemental searches, 37 studies met 
the inclusion criteria for abstraction.1–3,6,7,10–41
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The earliest study identified was published in 1983 with 28 studies (32 cohorts) published 
between 2010 and June 2014 (Table 1). Two studies reported data from multiple cohorts. 
The study by Rothwell et. al. analyzed data from four cohorts.3 The study by Poortvliet et. 
al. reported results for cohorts at two different follow-up lengths: a short-term follow-up 
cohort (included countries: Ireland, Scotland, the Netherlands) and a long-term follow-up 
cohort that included the subset of individuals from Scotland.31 Overall, the 37 included 
studies comprised 41 different cohorts. Cohort sample sizes ranged from 144 to 58,228 
participants. Cohorts included general population/community-based samples (4 cohorts), 
elderly populations (5 cohorts), individuals with hypertension (11 studies), a history of 
stroke (5 cohorts), on hemodialysis (8 cohorts), with chronic kidney disease not on 
hemodialysis (3 cohorts), individuals with type 2 diabetes (4 cohort), and post-menopausal 
women (1 cohort). A number of countries were represented including populations 
exclusively from Australia, Hong Kong, Italy, Japan, Korea, Taiwan, the Netherlands, the 
U.K., and the U.S., as well as aggregated populations from a number of countries.
Visit-to-Visit Variability Metrics
The number of visits used to derive VVV ranged from 3 visits to 156 visits with 13 cohorts 
using the same number of visits for each participant (Table 2). The number of BP readings 
per visit was 1 measure (9 cohorts), 2 measures (19 cohorts), 3 measures (8 cohorts), varied 
(2 cohorts), or was not reported (3 cohorts). Across the cohorts, the time-interval between 
visits ranged from 2 days to 3–4 years. The time-interval between visits was uniform for 26 
cohorts, varied for 13 cohorts, and was not reported for 2 cohorts. Among the included 
cohorts, 22 reported one measure of VVV (e.g., SD) and 8 reported two measures of VVV 
(e.g., SD and coefficient of variation [CV]). The remaining cohorts reported more than 2 
VVV measures with six different measures of VVV reported for one cohort. The most 
common measures used to quantify VVV were SD (23 cohorts) and CV (21 cohorts). 
Nineteen other VVV measures were reported. VVV of SBP was reported in 37 cohorts, 
VVV of DBP was reported in 21 cohorts, VVV of MAP was reported in 2 cohorts, and VVV 
of PP was reported in 7 cohorts. VVV of SBP and VVV of DBP were both reported in 20 
cohorts.
VVV of SBP and Outcomes
SD of SBP, modeled as a continuous variable, was associated with an increased risk for 
stroke in 3 of 9 analyses, stroke mortality in 0 of 1 analyses, CHD in 4 of 6 analyses, CHD 
mortality in 0 of 1 analyses, CVD in 3 of 8 analyses, CVD mortality in 5 of 9 analyses, all-
cause mortality in 4 of 7 analyses, and a composite outcome of all-cause mortality/CVD in 1 
of 1 analyses (Table 3, left panel). Modeled as a categorical variable, increased risk was 
present in the highest versus lowest SD of SBP category in the majority of analyses for 
stroke, CVD, CVD mortality, and all-cause mortality, but not stroke mortality, CHD, or 
CHD mortality (Table 4, left panel). Mean BP was included as a covariate in 22 of the 24 
cohorts (91.7%) which examined SD of SBP and outcomes.
CV of SBP modeled as a continuous variable was associated with each outcome except 
stroke and CVD mortality in the majority of analyses (Table 3, right panel). Modeled as a 
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categorical variable, increased risk was present in the highest versus lowest category of CV 
of SBP in the majority of analyses for stroke, CVD, and all-cause mortality, but not stroke 
mortality, CHD, or CHD mortality (Table 4, right panel). Results for VVV of SBP using 
measures other than SD or CV modeled as a continuous variable are presented in 
Supplemental Table S1 and as categorical variable in Supplemental Table S2.
In total, 181 of 312 (58.0%) analyses showed a positive significant association between 
VVV of SBP and outcomes (Table 5). Results were similar after excluding studies among 
hemodialysis patients and studies that quantified VVV of SBP using visits separated by >1 
year (Supplemental Table S3). At least one positive significant association was reported in 
31 of the 37 cohorts that reported data for VVV of SBP. Meta-analyses of SD of SBP 
modeled as a continuous variable showed positive significant associations for stroke, CHD, 
CVD mortality, and all-cause mortality, but not CVD (Figure 2). Funnel plots and regression 
testing found no evidence of publication bias among the pooled studies for VVV of SBP 
(p=0.698).
VVV of DBP and Outcomes
SD of DBP was associated with outcomes in 5 of 19 analyses when modeled as a continuous 
variable (Supplemental Table S4, left panel) and in 12 of 38 analyses when modeled as a 
categorical variable (Supplemental Table S5, left panel). CV of DBP was associated with 
outcomes in 12 of 41 analyses (Supplemental Table S4, right panel and Supplemental Table 
S5, right panel). Results for VVV of DBP metrics other than SD or CV are provided in 
Supplemental Table S6 for continuous and Supplemental Table S7 for categorical analyses.
In total, 61 of 188 (32.4%) analyses showed a significant positive association between VVV 
of DBP and outcomes (Table 5). Results were similar after excluding studies among 
hemodialysis patients and studies that quantified VVV of DBP using visits separated by >1 
year (Supplemental Table S3). At least one significant positive association was reported in 
11 of the 21 cohorts that reported data for VVV of DBP. A significant negative association 
was reported in one cohort. Meta-analyses of SD of DBP modeled as a continuous variable 
showed significant associations for CHD and CVD mortality, but not stroke or all-cause 
mortality (Supplemental Figure S1).
VVV of PP, VVV of MAP, and Outcomes
Modeled as continuous or categorical variables, VVV of PP metrics (SD, CV, and other) 
were associated with increased risk in less than 50% of reported analyses (Supplemental 
Tables S8, S9, and S10). Only two studies evaluated VVV of MAP and outcomes 
(Supplemental Tables S11 and S12). In total, 10 of 34 (29.4%) analyses showed a significant 
association between VVV of PP and outcomes and 3 of 5 analyses showed a significant 
association between VVV of MAP and outcomes (Table 5). Summary results excluding 
studies among hemodialysis patients and studies that quantified VVV of PP or MAP using 
visits separated by >1 year are reported in Supplemental Table S3.
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In this systematic review, we identified 41 cohorts that evaluated the association of VVV of 
BP with cardiovascular outcomes and/or all-cause mortality. A rigorous meta-analysis to 
summarize all published data was not possible because of the large heterogeneity in 
quantifying, defining and reporting VVV. Pooling the available data, statistically significant 
associations, albeit modest in magnitude, were observed between VVV of SBP and 
outcomes including stroke, CHD, CVD mortality, and all-cause mortality.
The vast majority of studies we identified reported an increased risk for outcomes with 
higher VVV of BP in at least one analysis. In many cases, the positive findings within a 
cohort were accompanied by additional analyses wherein no association was observed. For 
example, the study by Hastie et al. reported 104 different analyses wherein 24 of 52 (46.1%) 
analyses for VVV of SBP and 10 of 52 (19.2%) analyses for VVV of DBP showed 
significant associations with outcomes.1 The mixed findings within studies underscores a 
need to more carefully consider negative results. Chance findings as a result of inflation of 
type I error rates with multiple analyses may also need more rigorous consideration. 
Nonetheless, the significant associations reported for many different outcomes (stroke, 
CHD, CVD, all-cause mortality) across many different populations (general population, 
chronic kidney disease, hypertension, diabetes, hemodialysis patients, etc.) suggests a 
potential role for VVV of BP as a CVD risk factor. It should be acknowledged that, given 
the rising and falling fluid volumes in hemodialysis patients, VVV of BP may be a different 
clinical entity in this population.
This review highlights a need for researchers to use standardized approaches when defining 
VVV of BP. The number of visits, time interval between visits, and the BP measurement 
protocols varied widely across studies. For example, the number of visits used to quantify 
VVV ranged from as few as 3 visits to as many as 156 visits and the time interval between 
visits ranged from 2 days to 3–4 years. It has been reported that VVV of BP is influenced by 
the number of visits used to calculate it, the time interval between visits, the BP 
measurement device, and the number of BP measurements per visit.42,43 These factors may 
affect the VVV of BP – outcome associations observed between studies. It has thus been 
suggested that adjustments should be made for the number of visits used to calculate VVV 
of BP and the time-interval between visits.42 Although VVV of BP was derived using the 
same number of visits for all participants in 13 cohorts and the same time-interval between 
visits in 26 cohorts, only 2 of the remaining cohorts20,29 adjusted for these factors. 
Moreover, there was inadequate description of the methodology used to quantify VVV of 
BP for several cohorts as the number of visits used to quantify VVV of BP, the time interval 
between visits, and the number BP measurements per visits were not reported.
A standardized approach to calculating VVV of BP is also needed. A total of 21 different 
metrics were used to calculate VVV of BP, with many studies reporting multiple metrics. 
The reporting of multiple metrics has made it challenging to interpret evidence on the 
association of VVV of BP and outcomes. It has been reported that many of the metrics 
provide largely redundant information.44 Therefore, future studies of VVV of BP may 
benefit from only reporting three metrics: a measure of variation around an individual’s 
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mean BP (SD, CV or SD independent of the mean), a measure of change in BP over time 
(average real variability or successive variation), and a measure of spikes in BP (peak BP).
VVV of SBP was more often investigated and reported in comparison to VVV of DBP. 
However, both showed associations with adverse outcomes in the meta-analysis we 
conducted. Although sparingly studied, VVV of PP and VVV of MAP were also associated 
with CVD and all-cause mortality in some studies.10,23,31 These data implicate VVV in all 
four BP indexes as having potential prognostic value. In the only study to analyze all four 
BP indexes, Hsieh et al showed VVV of SBP, DBP, and MAP, but not VVV of PP, to be 
associated with all-cause mortality. In contrast, VVV of PP was the only BP index 
associated with CVD mortality in this study. Future studies are, therefore, still needed to 
determine which BP index carries the greatest prognostic information.
Several limitations should be considered when interpreting our findings. First, because of 
the aforementioned methodological considerations, a meta-analysis including all 41 cohorts 
was not possible. Second, studies adjusted for different sets of confounders which could 
have contributed to the heterogeneity of results. Third, given the small number of studies 
available for pooling we could not perform meta-regression to evaluate factors associated 
with the heterogeneity of results across studies. Finally, the majority of studies included 
were secondary analyses of randomized controlled trials or observational studies. 
Methodological factors that influence VVV of BP (e.g., number of visits, time interval 
between visits) may have affected the VVV of BP to outcomes association that we report. 
Future studies using rigorous methodology should be conducted to provide a better 
assessment of the VVV of BP – outcome association and determine the clinical utility of 
measuring VVV of BP. As ambulatory BP is considered to have superior prognostic value to 
clinic BP,45 another important area for future studies is to determine the clinical relevance of 
VVV of ambulatory BP.
PERSPECTIVES
In the current systematic review, an association between VVV of BP and CVD and mortality 
outcomes was present in some but not all studies. When data were available to pool, VVV of 
SBP was associated with a modest increased risk for stroke, CHD, CVD mortality, and all-
cause mortality and VVV of DBP was associated with an increased risk for CHD and CVD 
mortality. The associations observed across a variety of populations suggest that VVV of BP 
may be a risk factor for CVD. However, the association between VVV of BP and outcomes 
that we report is limited by the various number of methodologies used to quantify VVV of 
BP. Thus, the clinical relevance of VVV of BP should be interpreted cautiously and is still 
unclear. Additional studies using standardized approaches for estimating VVV of BP are 
needed to clarify its prognostic value.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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This is the first study to systematically review and meta-analyze the published literature 
on the association between visit-to-visit variability (VVV) of blood pressure (BP) and 
health outcomes.
What is relevant?
Pooled estimates showed that VVV of BP was associated with a modest increased risk 
for cardiovascular disease and all-cause mortality. This finding, however, is limited by 
the small amount of available data to pool and lack of a standardized approach for 
estimating VVV of BP. Therefore, caution should be used in intepreting it’s clinical 
relevance.
Summary
Data from published studies suggest that VVV of BP may be a novel cardiovscular risk 
factor. However, the modest associations from pooled estimates may limit its potential 
clinical relevance. Additional studies using standardized approaches for estimating VVV 
of BP are needed to clarfiy its prognositc value.
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Flow diagram of article selection for the systematic review.
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Association of the standard deviation of systolic blood pressure with outcomes. Sizes of the 
squares are proportional to the number of events in each study. Vertical lines denote 95% 
confidence intervals. The width of the diamond shapes represents the 95% confidence 
intervals in pooled analyses.
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Table 3
Results reported for continuous analysis of standard deviation and coefficient of variation of systolic blood 
pressure and outcomes.
Standard deviation Coefficient of variation
Study HR/OR/RR (95% CI) Units* HR/OR/RR (95% CI) Units*
Stroke
Chowdhury et al, 2014 (In-trial) 1.07 (1.04 – 1.10) 1 mmHg - -
Hata, J. et al, 2013 1.08 (0.93 – 1.25) 5 mmHg 1.08 (0.93 – 1.25) 3.4%
Hata, Y. et al, 2000 - - 1.15 (1.03 – 1.29) 2%
Lau et al, 2013 1.13 (0.83 – 1.52) 6 mmHg - -
Lau et al, 2014 - - 1.02 (0.97 – 1.07) 4%





Poortvliet et al, 2012 (Long-
term follow-up cohort)
1.1 (1.0 – 1.3) 4.88 mmHg - -
Pringle et al, 2003
(Treatment group)
1.50 (0.93 – 2.41) 5 mmHg - -
Pringle et al, 2003 (Placebo
group)
0.84 (0.50 – 1.39) 5 mmHg - -
Rothwell et al, 2010
(ASCOT-BPLA ABPM
Substudy)
1.69 (1.34 – 2.11) 1 SD 1.78 (1.40 – 2.26) 1 SD
Shimbo et al, 2012 1.16 (1.08 – 1.24) 5 mmHg - -
Stroke Mortality
Yinon et al, 2013 1.51 (0.93 – 2.44) 1 SD of Log - -
CHD
Chowdhury et al, 2014 (In-trial) 1.09 (1.05 – 1.12) 1 mmHg - -
Hata, J. et al, 2013 1.32 (1.11 – 1.55) 5 mmHg 1.29 (1.10 – 1.52) 3.4%
Lau et al, 2013 1.14 (0.75 – 1.73) 6 mmHg - -
Lau et al, 2014 - - 0.95 (0.85 – 1.06) 4%





Poortvliet et al, 2012 (Long-
term follow-up cohort)
1.1 (1.0 – 1.3) 5 mmHg - -
Rothwell et al, 2010
(ASCOT-BPLA ABPM
Substudy)
1.43 (1.23 – 1.67) 1 SD 1.49 (1.27 – 1.75) 1 SD
CHD Mortality
Yinon et al, 2013 0.78 (0.56 – 1.08) 1 SD of Log - -
CVD
Chowdhury et al, 2014 (In-trial) 1.05 (1.04 – 1.06) 1 mmHg - -
Eguchi et al, 2012 0.75 (0.48 – 1.17) 5 mmHg - -
Hata, J. et al, 2013 1.18 (1.07 – 1.30) 5 mmHg 1.18 (1.07 – 1.29) 3.4%
Mancia et al, 2012 0.999 (0.952 – 1.048) NR 0.976 (0.906 – 1.051) NR
Pringle et al, 2003
(Treatment group)
0.88 (0.64 – 1.20) 5 mmHg - -
Pringle et al, 2003 (Placebo 1.04 (0.74 – 1.47) 5 mmHg - -
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Standard deviation Coefficient of variation
Study HR/OR/RR (95% CI) Units* HR/OR/RR (95% CI) Units*
group)
Rossignol et al, 2012 Not statistically sig.
(Data NR)
NR 1.08 (1.03 – 1.14) NR
Rothwell et al, 2010
(ASCOT-BPLA ABPM
Substudy)
1.50 (1.31 – 1.72) 1 SD 1.57 (1.37 – 1.80) 1 SD
CVD Mortality
Chang et al, 2014 - - 1.10 (0.89 – 1.37) 10%
Di Iorio et al, 2013 - - 1.21 (1.05 – 1.33) NR
Hata, J. et al, 2013 1.30 (1.13 – 1.50) 5 mmHg 1.29 (1.12 – 1.48) 3.4%
Hsieh et al, 2012 1.05 (0.96 – 1.14) NR 1.08 (0.95 – 1.22) NR
Lau et al, 2013 1.53 (1.05 – 2.25) 6 mmHg - -
Lau et al, 2014 - - 1.25 (0.99 – 1.57) 4%





Poortvliet et al, 2012 (Long-
term follow-up cohort)
1.2 (1.1 – 1.4) 5 mmHg - -
Pringle et al, 2003
(Treatment group)
1.15 (0.76 – 1.74) 5 mmHg - -
Pringle et al, 2003 (Placebo
group)
0.82 (0.49 – 1.38) 5 mmHg - -
Tozawa et al, 1999 - - 1.78 (0.94 – 3.37) 1%
Yinon et al, 2013 (All CVD
Mortality)
1.41 (1.04 – 1.92) 1 SD of Log - -
Yinon et al, 2013 (Major
CVD Mortality)
1.84 (1.27 – 2.66) 1 SD of Log - -
All-Cause Mortality
Chang et al, 2014 - - 1.18 (1.02 – 1.36) 10%
Di Iorio et al, 2012
(Before Dialysis Entry)
- - 1.06 (1.02 – 1.09) NR
Di Iorio et al, 2012
(Including Time After
Dialysis Inception)
- - 1.05 (1.03 – 1.09) NR
Di Iorio et al, 2013 - - 1.02 (0.95 – 1.06) NR
Hata, J. et al, 2013 1.29 (1.17 – 1.43) 5 mmHg 1.28 (1.16 – 1.40) 3.4%
Hsieh et al, 2012 1.05 (1.01 – 1.09) NR 1.06 (1.00 – 1.12) NR
Lau et al, 2013 1.20 (0.96 – 1.51) 6 mmHg - -
Lau et al, 2014 - - 1.23 (1.07 – 1.41) 4%





Poortvliet et al, 2012 (Long-
term follow-up cohort)
1.1 (1.1 – 1.2) 5 mmHg - -
Selvarajah et al, 2014 1.08 (1.01 – 1.16) 1 mmHg 1.13 (1.02 – 1.24) 1%
Tozawa et al, 1999 - - 1.63 (1.05 – 2.53) 1%
Yinon et al, 2013 0.99 (0.82 – 1.74) 1 SD of Log - -
Composite of all-cause
mortality and fatal and non-
fatal CVD
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Standard deviation Coefficient of variation
Study HR/OR/RR (95% CI) Units* HR/OR/RR (95% CI) Units*
Mallamaci et al, 2013 1.15 (1.03 – 1.27) 5 mmHg 1.17 (1.02 – 1.34) 5%
CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular disease; HR, hazard ratio; MI, myocardial infarction; NR, not reported; 
OR, odds ratio; RR, relative risk; SD, standard deviation; VVV, visit-to-visit variability.
*
Units represented by the measure of association
Dash indicates data were not examined.
For each outcome, data in table are sorted in alphabetical order by first author’s last name.
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